Uncontrolled thrombocytosis in chronic myeloproliferative disorders

British Journal of Haematology
C M KesslerR J Havlik

Abstract

A retrospective study was performed to examine the natural course of uncontrolled thrombocytosis associated with chronic myeloproliferative disorders. Thirty-eight patients with polycythaemia rubra vera (PV), myelofibrosis/myeloid metaplasia (MM), chronic myelogenous leukaemia (CML) or essential thrombocythaemia (ET) had platelet counts greater than 1000 X 10(9)/1 and were followed closely for a total of 246 patient years. Eleven of the patients experienced haemorrhagic episodes. Bleeding was twice as frequent in patients over 59 years old as in those younger and no bleeding occurred in those less than 51 years of age. There was no correlation between frequency of bleeding and extent of thrombocytosis. Bleeding events occurred concurrently with use of anti-inflammatory agents in 32% of episodes. The gastrointestinal tract was the most frequent site. Documented thrombotic events occurred in three patients, two of whom had PV with haematocrits greater than 53%. This study suggests that the thrombocytosis of myeloproliferative processes may pose a less serious threat than originally thought and that aggressive lowering of the platelet count may not be indicated in all cases.

References

Oct 27, 1979·Lancet·P R HumphreyE Zilkha
Mar 1, 1979·Transfusion·A L Panlilio, R F Reiss
Apr 1, 1975·Annals of Internal Medicine·A D Ginsburg
Aug 31, 1974·British Medical Journal·F E PrestonR G Malia
Jul 1, 1971·Journal of Comparative and Physiological Psychology·M A Nathan, O A Smith
Mar 1, 1972·American Journal of Clinical Pathology·J A NeemehC A Owen
Oct 9, 1969·The New England Journal of Medicine·F Rodriguez-ErdmannW C Moloney
Feb 19, 1981·The New England Journal of Medicine·P D BerkL R Wasserman
Oct 1, 1955·British Journal of Haematology·R M HARDISTY, H H WOLFF
May 9, 1959·Lancet·L SZURA W GOOLDEN
Nov 1, 1962·Acta Medica Scandinavica·E CHIEVITZ, T THIEDE
Jul 1, 1962·Annals of Internal Medicine·J A PITCOCKR S MENDELSOHN
Dec 5, 1963·The New England Journal of Medicine·L R WASSERMAN, H S GILBERT

❮ Previous
Next ❯

Citations

Jan 1, 1993·Journal of Clinical Apheresis·B C McLeodH G Klein
Sep 1, 1996·Journal of the Neurological Sciences·T Tatlisumak, M Fisher
Oct 1, 1995·Critical Reviews in Oncology/hematology·R LandolfiC Patrono
Mar 1, 1989·Clinical Radiology·S WagnerK Sikora
Jul 1, 1994·Mayo Clinic Proceedings·A Tefferi, H C Hoagland
Jan 1, 1996·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A SagripantiA Carpi
Dec 22, 1999·British Journal of Haematology·Y Dror, V S Blanchette
Feb 14, 2002·British Journal of Haematology·Jerry L Spivak
Jan 3, 1991·The New England Journal of Medicine·J N George, S J Shattil
Oct 19, 1999·Journal of Pediatric Hematology/oncology·Y DrorV S Blanchette
Jun 1, 1991·British Journal of Haematology·T C Pearson
Jun 1, 1995·The Journal of Obstetrics and Gynaecology·Z RashidN Adeeb
Jan 26, 1991·BMJ : British Medical Journal·B J Boughton
Mar 1, 1994·Annals of Hematology·R J SchlemperJ C Eikenboom
Jan 1, 1991·Leukemia & Lymphoma·A HattoriA Shibata
Jan 1, 1997·Cancer Investigation·S J Kempin
Jan 26, 2005·British Journal of Haematology·M A Elliott, A Tefferi
Jan 20, 2000·Baillière's Clinical Haematology·A Tefferi, M N Silverstein
Feb 1, 1986·British Journal of Haematology·J E Van de PetteG Wetherley-Mein
Jun 1, 1987·Baillière's Clinical Haematology·T C Pearson, M Messinezy
Jun 1, 1987·Baillière's Clinical Haematology·J A Copplestone
Jan 5, 2002·Neurologic Clinics·Deborah T Blumenthal, Martha J Glenn
Oct 1, 1995·Journal of Vascular Surgery·M JohnsonK Johansen
Mar 22, 2000·Clinical and Applied Thrombosis/hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis·M L RandiA Girolami
Nov 26, 1997·American Journal of Hematology·A RegevM Lahav
Oct 17, 2017·Case Reports in Gastroenterology·Tomoko OchiaiMasashi Yoneda
May 1, 1996·Stroke; a Journal of Cerebral Circulation·P T AkinsC P Derdeyn
Mar 15, 1988·Cancer·J J Lahuerta-PalaciosJ Montero-Castillo
Aug 1, 1990·Cancer·P FenauxF Bauters
Jun 4, 2019·Blood·Jerry L Spivak
Mar 23, 2011·Expert Review of Anticancer Therapy·Jerry L Spivak, Hans Hasselbalch
Sep 1, 1985·Scandinavian Journal of Haematology·G LuzzattoA Girolami
Oct 1, 1989·American Journal of Hematology·M G Conlan, W D Haire
Jun 1, 1987·American Journal of Hematology·H J IlandL R Wasserman
Jan 1, 1987·Clinical and Laboratory Haematology·P R Kelsey, C G Geary
Jan 27, 2009·Proceedings·Palwasha N KhanZhiyong Li

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.